DigiTx Partners

Cerula Care is a behavioral health company dedicated to supporting individuals with advanced chronic conditions. The organization offers virtual care services that include care management, coaching, and psychiatry. Its focus lies in addressing mental health issues such as anxiety, depression, substance use disorders, and post-traumatic stress disorder. By providing these tailored services, Cerula Care aims to enhance the behavioral health outcomes of its patients, ensuring they receive the necessary support to manage their conditions effectively.

StrokeDx specializes in creating innovative and portable diagnostic devices aimed at improving stroke care. The company leverages advanced machine learning and artificial intelligence to enhance the diagnostic accuracy and imaging capabilities of its microsensors. These devices are designed to detect blood in the brain and generate predictive images of stroke locations, allowing for rapid triage and diagnosis. By offering a cost-effective alternative to traditional methods, StrokeDx aims to reduce the time to treatment, ultimately improving patient outcomes in emergency situations.

CardioSignal is a mobile application and certified medical device focused on detecting heart diseases, particularly atrial fibrillation. Originating as an academic spinoff, the company leverages a decade of research and algorithm development to offer a digital cardiac biomarker for self-monitoring and remote care. Its software provides features such as atrial fibrillation detection, vital sign monitoring, measurement history, insights, and reminders, all aimed at enabling users to prevent strokes and heart attacks while improving overall health outcomes. CardioSignal operates under the brand of Precordior, showcasing its commitment to advancing cardiac care through innovative technology.

Rune Labs, Inc. is a San Francisco-based company that develops a software-as-a-service platform focused on neuromodulation systems to enhance the management of complex therapies. Founded in 2018, the platform processes brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. It supports pharmaceutical companies in creating and implementing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The cloud-based platform allows therapy developers to efficiently manage data and run complex algorithms across multiple patients, facilitating the delivery of precision medicine and identifying potential responders for clinical trials. By integrating with emerging neuromodulation devices, Rune Labs enables clients to leverage large datasets for therapy development and adaptive therapy applications.

Ciba Health is a digital therapeutics and virtual care platform that focuses on personalized health solutions for chronic conditions. The company employs a precision health approach to enhance both physical and mental well-being, promoting self-care and empowering patients to take charge of their health. Ciba Health's platform emphasizes patient-centered, root-cause treatment methods and a value-based care delivery model. It provides integrated care through easy access to multidisciplinary care teams, utilizing advanced technology to implement tailored treatment plans. This holistic approach addresses various aspects of health, including lifestyle, sexual, and mental health, ultimately aiming to improve overall patient outcomes.

Tali AI is a company focused on enhancing the efficiency of healthcare professionals through its voice-enabled virtual assistant, which integrates seamlessly with electronic health records (EHR). This technology allows physicians to dictate notes directly into the EHR, streamlining the documentation process for patient and drug information. Additionally, Tali AI offers a platform that consolidates a vast library of evidence-based resources, enabling front-line healthcare workers to quickly access answers to frequently asked questions without the need to navigate multiple resources. This innovative approach aims to reduce administrative burdens on healthcare providers, ultimately improving patient care.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

Mightier is a gaming platform designed to assist children in regulating their emotions through scientifically-backed methods. Founded in 2016 and based in Boston, Massachusetts, the platform features bioresponsive video games developed in collaboration with Boston Children's Hospital and Harvard Medical School. The games utilize a biofeedback heart rate monitor that adjusts the difficulty level based on the player's emotional state, helping children learn to manage their feelings in real-time. By engaging with these interactive experiences, children with behavioral and emotional challenges can discover their emotional strengths and develop skills to harness their emotions in everyday situations.

Rune Labs, Inc. is a San Francisco-based company that develops a software-as-a-service platform focused on neuromodulation systems to enhance the management of complex therapies. Founded in 2018, the platform processes brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. It supports pharmaceutical companies in creating and implementing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The cloud-based platform allows therapy developers to efficiently manage data and run complex algorithms across multiple patients, facilitating the delivery of precision medicine and identifying potential responders for clinical trials. By integrating with emerging neuromodulation devices, Rune Labs enables clients to leverage large datasets for therapy development and adaptive therapy applications.

Cleerly is a healthcare company focused on improving the prevention of heart attacks through innovative digital care pathways. It aims to establish a new standard for coronary artery disease by combining advanced clinical science with cutting-edge artificial intelligence. Cleerly's platform offers a non-invasive approach that quantifies and characterizes plaque buildup in coronary arteries, enhancing the understanding of cardiovascular health. By providing actionable clinical insights, the company enables healthcare providers to better identify at-risk patients and implement early treatment strategies. Ultimately, Cleerly's data-driven solutions aspire to deliver significant value to the healthcare system while improving heart health outcomes for individuals susceptible to heart attacks.

Nēsos specializes in the development and commercialization of electrical field treatments aimed at addressing neurological disorders. The company focuses on creating therapeutic earbuds that facilitate drug-free, non-invasive treatments by utilizing existing nerve pathways to stimulate target brain regions. This innovative approach enables medical practitioners to treat conditions such as rheumatoid arthritis by harnessing the principles of neuroplasticity. Nēsos benefits from the collaboration of prominent clinical and scientific experts from esteemed academic institutions, including Stanford, Harvard, and Mount Sinai, among others. Co-founded by Konstantinos Alataris and a team of neuroscientists, Nēsos is committed to advancing therapies that improve immune function and overall neurological health.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Rune Labs, Inc. is a San Francisco-based company that develops a software-as-a-service platform focused on neuromodulation systems to enhance the management of complex therapies. Founded in 2018, the platform processes brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. It supports pharmaceutical companies in creating and implementing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The cloud-based platform allows therapy developers to efficiently manage data and run complex algorithms across multiple patients, facilitating the delivery of precision medicine and identifying potential responders for clinical trials. By integrating with emerging neuromodulation devices, Rune Labs enables clients to leverage large datasets for therapy development and adaptive therapy applications.

G-Tech Medical is focused on developing a wireless, wearable, and disposable electrode patch known as the GutCheck, which measures the electrical activity in the gastrointestinal tract, specifically the stomach, small intestine, and colon. This innovative device addresses a significant gap in diagnosing functional gastrointestinal disorders, such as abdominal pain, constipation, diarrhea, and bloating, which are often overlooked by traditional diagnostic methods like colonoscopies and CT scans. By monitoring myoelectrical signals over several days, the GutCheck patch provides physicians with valuable insights into gastrointestinal motility, enabling them to better tailor treatments for their patients. This non-invasive solution aims to improve clinical outcomes and reduce healthcare costs associated with gastrointestinal conditions.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, specializes in developing innovative solutions for the detection and management of neurocognitive and neuromotor disorders. The company has created neuroQWERTY, an artificial intelligence tool that passively collects data through everyday use of electronic devices, enabling 24/7 monitoring of disease progression and therapeutic effectiveness. This frictionless and non-invasive platform captures subtle changes in user interactions, such as typing and touchscreen behavior, which are often overlooked by traditional clinical assessments. With proven capabilities demonstrated in extensive clinical trials, nQ Medical aims to facilitate early detection of disorders like Alzheimer's, Parkinson's, and multiple sclerosis, while offering a cost-effective alternative to current diagnostic methods. By providing patients and clinicians with a reliable means to track disease status and treatment impact, nQ Medical is positioned to enhance the management of neurological conditions significantly.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Embr Labs Inc. is a company based in Somerville, Massachusetts, that specializes in developing thermal comfort devices aimed at enhancing human well-being. Founded in 2014 and originally known as Wristify Inc., Embr Labs has created innovative technology that uses temperature to influence the autonomic nervous system, helping users manage conditions such as hot flashes, sleep disturbances, and anxiety. The company's wearable devices, combined with a mobile app and cloud infrastructure, provide a unique platform for thermal stimulation and digital interventions, allowing users to track and manage their symptoms effectively. With tens of thousands of customers across 170 countries, Embr Labs has recorded over 100 million minutes of thermal interventions. The technology originated from the founders' work as engineering students at MIT and has received significant backing from investors and over $2.5 million in grants from various organizations.

Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.

Savonix, Inc. is a San Francisco-based company that specializes in developing a digital neuro-cognitive assessment and brain health platform. Founded in 2014, its flagship product, Savonix Mobile, allows users to perform clinically recognized cognitive assessments on mobile devices. This platform provides accessible tests covering various cognitive domains, such as memory and implicit learning, which are guided by virtual clinicians. Savonix's assessments are designed to help healthcare providers, researchers, and insurers understand cognitive risks, including those related to dementia, and to inform treatment planning and diagnosis. The company has established strategic partnerships with notable institutions, including New York University and several biotech firms. Unique features of the platform include a 3D gaming component that generates additional cognitive insights without requiring separate tests, enhancing the understanding of cognitive function in aging populations. Savonix aims to deliver an affordable, scalable, and actionable solution for monitoring cognitive health, making it a leader in the field of digital cognitive assessment.

LifeLink Systems is a healthcare technology company that specializes in conversational engagement through its innovative chatbot platform. The company partners with major healthcare systems and pharmaceutical companies to enhance patient communication via mobile and messaging channels. By providing personalized, natural, and contextual conversations, LifeLink's chatbots automate numerous critical patient interactions before, during, and after healthcare visits. This approach not only streamlines operational efficiency but also boosts customer satisfaction and fosters brand loyalty. LifeLink's platform is designed to optimize patient engagement throughout the entire care continuum, allowing healthcare providers to connect with patients in their preferred channels while improving overall profitability.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Tissue Analytics, Inc. is a company that develops a mobile application designed to facilitate the measurement and analysis of chronic wounds, burns, and skin conditions. This innovative solution allows home health agencies, nursing homes, and medical practices to send patient photographs and perform wound analysis. The application automatically generates formatted patient reports and enables tracking of patient progress regarding their treatments. Additionally, it provides tools for remote patient evaluation and management, utilizing skin and wound analysis algorithms to measure, segment, and classify images. The platform ensures secure transport of protected health information from the patient's bedside to the provider's desktop. Established in 2014 and based in Baltimore, Maryland, Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. The company has formed a strategic alliance with MolecuLight Inc. to further enhance its offerings.

Siris Medical, Inc. is a technology company based in Redwood City, California, that specializes in artificial intelligence-driven decision support systems for radiation therapy in cancer treatment. Founded in 2013, the company has developed the InsightRT Software Suite, which includes tools such as QuickMatch and PlanMD, designed to assist clinicians in managing patient treatment plans effectively. This platform is notable for being the first artificial intelligence decision support system in radiation oncology to receive FDA 510(k) clearance. It employs machine learning to provide real-time insights into treatment plan outcomes, helping clinicians make informed decisions regarding dosage, prescription, and treatment modalities, ultimately aiming to minimize side effects and expedite the initiation of patient treatment. Siris Medical is also affiliated with various innovation incubators, including North Shore InnoVentures and the UCSF / QB3 Rosenman program.

Savonix, Inc. is a San Francisco-based company that specializes in developing a digital neuro-cognitive assessment and brain health platform. Founded in 2014, its flagship product, Savonix Mobile, allows users to perform clinically recognized cognitive assessments on mobile devices. This platform provides accessible tests covering various cognitive domains, such as memory and implicit learning, which are guided by virtual clinicians. Savonix's assessments are designed to help healthcare providers, researchers, and insurers understand cognitive risks, including those related to dementia, and to inform treatment planning and diagnosis. The company has established strategic partnerships with notable institutions, including New York University and several biotech firms. Unique features of the platform include a 3D gaming component that generates additional cognitive insights without requiring separate tests, enhancing the understanding of cognitive function in aging populations. Savonix aims to deliver an affordable, scalable, and actionable solution for monitoring cognitive health, making it a leader in the field of digital cognitive assessment.

Juji is a company focused on democratizing artificial intelligence to advance human interaction. It offers a cloud-based software platform that enables users to create customized AI chatbots without requiring technical expertise. The platform integrates advanced technologies such as deep learning, natural language processing, and machine learning, making them accessible to non-technical business professionals. Juji's chatbots can be integrated into websites and mobile applications, performing various functions such as greeting visitors, understanding their needs, resolving queries, and conducting qualitative assessments. Additionally, the platform provides real-time audience analytics, including topic summarization of user conversations, which helps clients plan effective next steps in their engagement strategies.

FITNESS & WELLNESS TRACKING MODULES All our platforms offer Bluetooth Smart (Low Energy) wireless, USB charging and data connectivity, Flash memory, and a choice of processing power & of sensors. -Now: 16 bit MCU and gyroscopes, accelerometers, compass, pressure & temperature sensors. -In Q2 2014: 32 bit MCU and, in addition to the above sensors, optional ones such as heart rate, oxygen, humidity, UV, muscle strain, etc.